Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Thoracic 3Gynecologic 3Gastrointestinal 3Plasma cell 2Other solid neoplasm 2Other hematologic neoplasm 2Lymphoid 2CNS 2Tumor-Agnostic 1Myeloid 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Glioblastoma 2Stroke 1Neurologic Manifestations 1Neoplasms 1Margins of Excision 1Communication 1Caregiver Burden 1Brain Neoplasms 1Brain Injuries, Traumatic 1Brain Injuries 1

Interventions

Magnetic Resonance Spectroscopy 73Temozolomide 68Specimen Handling 48Radiotherapy 40Radiosurgery 29Bevacizumab 26Radiation 25Cyclophosphamide 25Nivolumab 21Biopsy 21pembrolizumab 20Carboplatin 16X-Rays 14Lomustine 13Ipilimumab 13fludarabine 12Irinotecan 12Vincristine 11Topotecan 11Surgical Procedures, Operative 11Cisplatin 11Blood Specimen Collection 11trametinib 9dinutuximab 9Immunoglobulin G 8Etoposide 8Doxorubicin 8lutetium Lu 177 dotatate 7fludarabine phosphate 7atezolizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Palliative Care × CNS × 90 days × Clear all
NCT07590726 2026-05-19

PIRe

Rigshospitalet, Denmark

Phase NA Not yet recruiting
160 enrolled
CNS

Brain Injuries, Traumatic, Margins of Excision, Caregiver Burden, Brain Injuries, Brain Neoplasms, Communication, Glioblastoma, Neoplasms, Neurologic Manifestations, Stroke

NCT07091864 2026-05-07

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Mayo Clinic

Phase NA Recruiting
116 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡